Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 10Prostatic Neoplasms 5Lung Neoplasms 5Endometrial Neoplasms 3Breast Neoplasms 3Stomach Neoplasms 2Rectal Neoplasms 2Pancreatic Neoplasms 2Oropharyngeal Neoplasms 2Neoplasms 2Urinary Bladder Neoplasms 1Ureteral Neoplasms 1Triple Negative Breast Neoplasms 1Thyroid Neoplasms 1Thyroid Diseases 1Stage I Mixed Cell Type Kidney Wilms Tumor 1Squamous Cell Carcinoma of Head and Neck 1Smoldering Multiple Myeloma 1Small Cell Lung Carcinoma 1Salivary Gland Neoplasms 1Pneumonia 1Pleuropulmonary blastoma 1Pathologic Complete Response 1Paranasal Sinus Neoplasms 1Pancreatitis, Chronic 1Neurocognitive Disorders 1Neuroblastoma 1Neoplasm Metastasis 1Nasopharyngeal Neoplasms 1Meningioma 1

Interventions

Magnetic Resonance Spectroscopy 8X-Rays 6Specimen Handling 6Phantoms, Imaging 6Nuclear Medicine Department, Hospital 5Biopsy 4ulixertinib 2tipifarnib 2tazemetostat 2selpercatinib 2palbociclib 2olaparib 2lutetium Lu 177 dotatate 2larotrectinib 2ivosidenib 2erdafitinib 2ensartinib 2LY3023414 2pembrolizumab 1neratinib 1cemiplimab 1brigatinib 1Watchful Waiting 1Vincristine 1Vemurafenib 1Temozolomide 1Radiotherapy, Conformal 1Radiotherapy 1Radiation 1Platinum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Ependymoma × Observation × 90 days × Clear all
NCT01096368 2026-04-30

Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Ependymoma

Children's Oncology Group

Phase 3 Completed
479 enrolled 24 charts

Ependymoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡